-- Arovella Therapeutics (ASX:ALA) said the requisitioning shareholder has withdrawn its April 8 notice, which called for a general meeting to appoint three directors, according to a Thursday Australian bourse filing.
Arovella Therapeutics had earlier said the notice "cannot be lawfully effected at a general meeting," and had invited the shareholder to formally withdraw the notice.
Its shares fell 3% in recent trading on Thursday.